NewAmsterdam Pharma Co N.V.

Ownership Transactions Reported by 18 Insiders

Symbol
NAMS, NAMSW on Nasdaq
Location
Gooimeer 2 35, Narrden, Netherlands

Insiders trading volume in the past year

NewAmsterdam Pharma Co N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ForGrowth NAP B.V. 10%+ Owner $272M -$30M -9.94% Dec 30, 2024
Bain Capital Life Sciences Investors, LLC 10%+ Owner $239M +$40M +20.1% Dec 13, 2024
James Topper Director $146M +$181K +0.12% Mar 26, 2024
Michael H. Davidson Chief Executive Officer, Director $4.13M +$168K +4.23% Jan 6, 2025
William A. Jones Jr Chief Commercial Officer $1.1M Jan 7, 2025
Johannes Jacob Pieter Kastelein Chief Scientific Officer, Director $868K -$4.1M -82.5% Jan 7, 2025
Louis G. Lange Director $813K Jan 6, 2025
Douglas F. Kling Chief Operating Officer $407K Jan 29, 2025
Juliette Berangere Audet Chief Business Officer $386K +$17.3K +4.71% Jan 7, 2025
Louise Kooij Chief Accounting Officer $383K -$707K -64.9% Jan 7, 2025
Mayur Ian Somaiya Chief Financial Officer $352K Jan 27, 2025
William Lewis Director $178K Jan 6, 2025
John W. Smither Director $178K Jan 6, 2025
Hilde Johanna van der Kamp Director $178K Jan 6, 2025
Mark C. McKenna Director $178K Jan 6, 2025
Hugo Alexander Slootweg Director Dec 29, 2023
Nicholas Downing Director Dec 29, 2023
Wouter Joustra Director Jul 16, 2024

Recent Insider Transactions by Companies or Individuals for NewAmsterdam Pharma Co N.V.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.